UA32254A - Method for treating chronic pyelonephritis in patients with diabetes mellitus - Google Patents

Method for treating chronic pyelonephritis in patients with diabetes mellitus

Info

Publication number
UA32254A
UA32254A UA99010505A UA99010505A UA32254A UA 32254 A UA32254 A UA 32254A UA 99010505 A UA99010505 A UA 99010505A UA 99010505 A UA99010505 A UA 99010505A UA 32254 A UA32254 A UA 32254A
Authority
UA
Ukraine
Prior art keywords
diabetes mellitus
patients
treating chronic
chronic pyelonephritis
pyelonephritis
Prior art date
Application number
UA99010505A
Other languages
Russian (ru)
Ukrainian (uk)
Inventor
Людмила Єгорівна Бобирьова
Людмила Егоровна Бобырева
Віталій Іванович Катеренчук
Виталий Иванович Катеренчук
Володимир Іванович Шепітько
Владимир Иванович Шепитько
Тетяна Миколаївна Юрченко
Татьяна Николаевна Юрченко
Віктор Миколайович Бобирьов
Виктор Николаевич Бобырев
Леонід Федорович Куроєдов
Леонид Федорович Куроедов
Original Assignee
Людмила Єгорівна Бобирьова
Людмила Егоровна Бобырева
Віталій Іванович Катеренчук
Виталий Иванович Катеренчук
Володимир Іванович Шепітько
Владимир Иванович Шепитько
Тетяна Миколаївна Юрченко
Татьяна Николаевна Юрченко
Віктор Миколайович Бобирьов
Виктор Николаевич Бобырев
Леонід Федорович Куроєдов
Леонид Федорович Куроедов
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Людмила Єгорівна Бобирьова, Людмила Егоровна Бобырева, Віталій Іванович Катеренчук, Виталий Иванович Катеренчук, Володимир Іванович Шепітько, Владимир Иванович Шепитько, Тетяна Миколаївна Юрченко, Татьяна Николаевна Юрченко, Віктор Миколайович Бобирьов, Виктор Николаевич Бобырев, Леонід Федорович Куроєдов, Леонид Федорович Куроедов filed Critical Людмила Єгорівна Бобирьова
Priority to UA99010505A priority Critical patent/UA32254A/en
Publication of UA32254A publication Critical patent/UA32254A/en

Links

Landscapes

  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)

Abstract

The invention relates to the medicine, namely to endocrinology. The inventive concept consists in developing the method providing the immunomodulating activity and decreasing insulin consumption resulting in the stable compensation of the disease and preventing the complications of both diabetes mellitus and pyelonephritis.
UA99010505A 1999-01-29 1999-01-29 Method for treating chronic pyelonephritis in patients with diabetes mellitus UA32254A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
UA99010505A UA32254A (en) 1999-01-29 1999-01-29 Method for treating chronic pyelonephritis in patients with diabetes mellitus

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
UA99010505A UA32254A (en) 1999-01-29 1999-01-29 Method for treating chronic pyelonephritis in patients with diabetes mellitus

Publications (1)

Publication Number Publication Date
UA32254A true UA32254A (en) 2000-12-15

Family

ID=74284157

Family Applications (1)

Application Number Title Priority Date Filing Date
UA99010505A UA32254A (en) 1999-01-29 1999-01-29 Method for treating chronic pyelonephritis in patients with diabetes mellitus

Country Status (1)

Country Link
UA (1) UA32254A (en)

Similar Documents

Publication Publication Date Title
MXPA05006994A (en) Compositions and methods for the prevention and control of insulin-induced hypoglycemia.
TNSN00206A1 (en) Method for treating diabetes
GB2338187A (en) Nutritional supplements for improving glucose metabolism
MXPA05007470A (en) Long acting insulin for reducing cardiovascular morbidity and mortality in prediabetic patients and patients with type 2 diabetes.
IL186182A0 (en) Control of blood glucose in diabetes treatment using pulmonarily administered insulin in combination with basal insulin
NZ504258A (en) Exendin 3 and 4 agonist compounds for the treatment of diabetes
EP0951911A3 (en) Method for administering aspb28-human insulin
BG105079A (en) Glucagon-like peptide-1 improves beta-cell response to glucose in subjects with impaired glucose tolerance
LT2002063A (en) Low-dose metformin and gliburide combinations for treating diabetes
WO2000016797A3 (en) Use of glp-1 or analogs in treatment of stroke
WO2003000242A3 (en) Method for the treatment of lymphedema using guaifenesin
EP1733734A3 (en) Placental alkaline phosphatase to control diabetes
SE9201573D0 (en) USE OF IGF-1
ZA200110408B (en) Methods for treating diabetes.
EP0808164A4 (en) Method for treatment of obesity using prolactin modulators and diet
AU2003252182A8 (en) Therapeutic treatment for the metabolic syndrome and type 2 diabetes
NZ332105A (en) Medicaments including human growth hormone for the treatment of type II diabetes and metabolic syndrome
WO1999064598A3 (en) Novel insulin analogs with enhanced zinc binding
WO2004060316A3 (en) Irs modulators
UA32254A (en) Method for treating chronic pyelonephritis in patients with diabetes mellitus
UA32255A (en) Method for treating diabetes mellitus
WO2004053107A3 (en) Methods for treating diabetes
WO2002043566A3 (en) Devices and methods for treating low blood sugar levels
WO2003072019A3 (en) Sequential therapy comprising a 20(s)-camptothecin compound and a pyrimidine base analog
WO2003082283A3 (en) Pharmaceutical composition with combined active agents and methods for using the same